185 related articles for article (PubMed ID: 24570393)
1. Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.
Isfoss BL; Busch C; Hermelin H; Vermedal AT; Kile M; Braathen GJ; Majak B; Berner A
Virchows Arch; 2014 Apr; 464(4):473-88. PubMed ID: 24570393
[TBL] [Abstract][Full Text] [Related]
2. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
[TBL] [Abstract][Full Text] [Related]
3. Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for γ-H2AX.
Yamada T; Toyoda T; Matsushita K; Cho YM; Akagi JI; Morikawa T; Mizuta Y; Ogawa K
Arch Toxicol; 2021 Feb; 95(2):715-726. PubMed ID: 33211169
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
6. Normal and neoplastic urothelial stem cells: getting to the root of the problem.
Ho PL; Kurtova A; Chan KS
Nat Rev Urol; 2012 Oct; 9(10):583-94. PubMed ID: 22890301
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer stem cells.
Tran MN; Goodwin Jinesh G; McConkey DJ; Kamat AM
Curr Stem Cell Res Ther; 2010 Dec; 5(4):387-95. PubMed ID: 20955163
[TBL] [Abstract][Full Text] [Related]
9. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.
Shin K; Lim A; Odegaard JI; Honeycutt JD; Kawano S; Hsieh MH; Beachy PA
Nat Cell Biol; 2014 May; 16(5):469-78. PubMed ID: 24747439
[TBL] [Abstract][Full Text] [Related]
10. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study.
Isfoss BL; Holmqvist B; Sand E; Forsell J; Jernström H; Olsson H
BMC Cancer; 2018 Feb; 18(1):230. PubMed ID: 29486751
[TBL] [Abstract][Full Text] [Related]
11. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
Rodriguez Pena MDC; Chaux A; Eich ML; Tregnago AC; Taheri D; Borhan W; Sharma R; Rezaei MK; Netto GJ
Virchows Arch; 2019 Sep; 475(3):349-356. PubMed ID: 31300876
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of denuded urothelium in bladder biopsy.
Levi AW; Potter SR; Schoenberg MP; Epstein JI
J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?
Herr HW; Al-Ahmadie H; Dalbagni G; Reuter VE
BJU Int; 2010 Nov; 106(10):1499-501. PubMed ID: 20346034
[TBL] [Abstract][Full Text] [Related]
15. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
[TBL] [Abstract][Full Text] [Related]
16. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
Siddiqui Z; Srivastava AN; Sankhwar SN; Dalela D; Singh V; Zaidi N; Fatima N; Bano I; Anjum S
Br J Biomed Sci; 2020 Apr; 77(2):69-75. PubMed ID: 31718471
[No Abstract] [Full Text] [Related]
17. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
18. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
20. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]